![Clario | Investments | Nordic Capital (1) Clario | Investments | Nordic Capital (1)](https://i0.wp.com/www.nordiccapital.com/media/hwcm4oj5/gettyimages-840632798_rt.jpg?anchor=center&mode=crop&quality=90&width=1440&height=720&rnd=133355310133070000&bgcolor=ffffff)
eClinical Solutions for the Pharmaceutical Industry
Clario delivers the leading endpoint technology solutions for clinical trials. The company fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives.
Company Background
- Experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals.
- Trusted partner to pharmaceutical and biotechnology companies.
- Unique combination of technology, scientific and therapeutic expertise with digital innovation and a strong focus on customer service.
Vision & Outlook
- Unlocking better evidence and transforming patients’ lives by driving further expansion of its operational capabilities.
- Continue to deliver best-in-class technology to enable richest clinical evidence.
- Boost diversity among patients in clinical trials, within its own inclusive workplace and among its suppliers.
Highlights & Updates
- Nordic Capitals re-invested alongside Astorg and Novo in 2020.
- Merger with Bioclinica created the company Clario in 2021.
- Recipient of the 2022 Top Workplaces award for D&I by Energage in 2022. Committed to the SBTi the same year.
SECTOR
Healthcare
Technology & Payments
REVENUES 2022
EUR 875 million
EMPLOYEES
3,775
OWNERSHIP
Fund IX
INVESTMENT DATE
2020
HEAD OFFICE
Philadelphia, Pennsylvania, USA
MANAGEMENT
Chris Fikry
CEO
Jason Knoblauch
CFO
CHAIRPERSON
RESPONSIBLE ADVISORS
Raj Shah
Partner | Head of Healthcare
Daniel Berglund
Partner | Co-Head of Healthcare | Head of U.S.
Nordic Capital's healthcare focus
Nordic Capital is one of the most active and experienced investors in healthcare globally, focusing on investments in companies throughout the healthcare space with potential to grow and expand into new markets and industry-leading innovations or value propositions.
Learn more here:
Healthcare
News & Views: Healthcare
The joint investment will foster future growth and innovation in the near-and long-term. During Nordic Capital’s ownership to date, Advanz Pharma has transforme…
Learn more
Investment will accelerate IntegriChain’s ambitious growth targets and cement its status as a leading platform for pharma manufacturers to bring their science t…
Learn more
Sunrise Medical, a world leader in advanced assistive mobility solutions, is pleased to announce its strategic acquisition of Ride Designs, a renowned industry …
Learn more
Since acquiring Advanz Pharma in 2021, Nordic Capital has supported the global pharmaceutical company’s growth and expansion agenda beyond Europe. Steffen Wagne…
Learn more
European Dental Group, a leading pan-European oral care services platform, announces a significant, transformative milestone on its journey. After rapidly growi…
Learn more
Prospitalia Group has appointed Dr. Benjamin I. Behar as new CEO and will operate under the new brand Vivecti Group.
Learn more
The companies have entered into an exclusive partnership agreement regarding the supply and commercialisation of five biosimilar candidates in Europe.
Learn more
In this Q and A, Raj Shah and Jonas Agnblad share Nordic Capital’s views on healthcare investments.
Learn more
corpuls is a leading global medical technology provider, focusing on high quality and innovative products for professional users in emergency situations. The C…
Learn more
Care Fertility has today announced new partnerships with the US based Reach Fertility and Spanish based IVF-Life. These are the latest of several fertility clin…
Learn more
The Binding Site has grown significantly under Nordic Capital’s and Five Arrows’ ownership, creating an industry leader in oncology testing for detection and mo…
Learn more
Nordic Capital has joined Equashield’s founders as a significant shareholder to support the Company’s next phase of growth
Learn more
The Binding Site, a global leader in specialist protein diagnostics, has appointed Mark Stevenson as new non-executive Chairperson. As the former Executive Vice…
Learn more
Nordic Capital today announced the agreement to buy CARE Fertility (“CARE”), a leading fertility clinic group in the UK. The investment is made in partnership w…
Learn more
Latest investment will help fuel the next phase of RLDatix’s rapid growth in governance, risk and compliance while accelerating its mission of making healthcare…
Learn more
Ontario Teachers’ Pension Plan Board (Ontario Teachers’) and PAI Partners have agreed to acquire Veonet, a leading pan-European network of ophthalmological clin…
Learn more
Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an …
Learn more
Ownership period defined by Acino’s transformation and growth to become leading provider of trusted and innovative pharmaceuticals in emerging markets. Leading …
Learn more
Stockholders to Receive $41.00 Per Share in Cash. Inovalon(Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today …
Learn more
Nordic Capital will further strengthen Equipe Zorgbedrijven’s successful concept of high-quality outpatient specialist care. The investment will drive Equipe Zo…
Learn more
Learn more
As a leading healthcare and technology investor and committed owner, Nordic Capital will further support and accelerate ArisGlobal’s growth in new product domai…
Learn more
Nordic Capital invests behind UVC’s next stage of growth, supporting its mission to provide leading care quality through empowered, passionate & dedicated v…
Learn more
Nordic Capital, a leading global healthcare private equity investor, invests in LEO Pharma and becomes an active minority owner and partner to the LEO Foundatio…
Learn more
Nordic Capital today announced a recommended cash offer to acquire the entire issued and to be issued limited voting share capital of ADVANZ PHARMA CORP. LIMITE…
Learn more
Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical tri…
Learn more
ERT, a global leader in clinical end-point data solutions, today announced that Bioclinica, a technological and scientific leader in clinical imaging, has agree…
Learn more
Nordic Capital expands its partner group with the promotion of Daniel Berglund, further strengthening its leadership team within two of its focus sectors; Healt…
Learn more
Nordic Capital is pleased to have won the Private Equity International Operational Excellence Award in the EMEA Large Cap Award category for its support of AniC…
Learn more